These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 9820411)

  • 1. Rectal cancer after sulindac therapy for a sporadic adenomatous colonic polyp.
    Matsuhashi N; Nakajima A; Shinohara K; Oka T; Yazaki Y
    Am J Gastroenterol; 1998 Nov; 93(11):2261-6. PubMed ID: 9820411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Role of suindac in the treatment of familial adenomatous polyposis coli].
    Landauer S; Halimi C; Caulin C; Bergmann JF
    Therapie; 1999; 54(6):675-82. PubMed ID: 10709439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NSAID effect on sporadic colon polyps.
    Hixson LJ; Earnest DL; Fennerty MB; Sampliner RE
    Am J Gastroenterol; 1993 Oct; 88(10):1652-6. PubMed ID: 8213705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of sulindac on sporadic colorectal adenomatous polyps.
    Matsuhashi N; Nakajima A; Fukushima Y; Yazaki Y; Oka T
    Gut; 1997 Mar; 40(3):344-9. PubMed ID: 9135523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment with sulindac of adenomatous polyps in familial polyposis].
    Cerdán FJ; Torres-Melero J; Martínez S; Gutiérrez del Olmo A; Balibrea JL
    Rev Esp Enferm Dig; 1995 Aug; 87(8):574-6. PubMed ID: 7577106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulindac in familial adenomatous polyposis: evaluation by nuclear morphometry.
    Fernández-López F; Conde-Freire R; Cadarso-Suárez C; García-Iglesias J; Puente-Domínguez JL; Potel-Lesquereux J
    Eur J Surg; 2001 May; 167(5):375-81. PubMed ID: 11419555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoprevention of colorectal cancer: two steps forward, one step back?
    Half EE; Arber N
    Future Oncol; 2006 Dec; 2(6):697-704. PubMed ID: 17155896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Celecoxib: new indication. Colorectal cancer: no preventive benefit.
    Prescrire Int; 2006 Feb; 15(81):13-5. PubMed ID: 16548099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sulindac in familial adenomatous polyposis coli--preliminary findings of a prospective study].
    Müller A; Hürlimann R; Meyenberger C; Staub P; Kobler E; Ammann R
    Schweiz Med Wochenschr; 1994 Apr; 124(15):651-4. PubMed ID: 8191270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colorectal adenomatous and hyperplastic polyps: smoking and N-acetyltransferase 2 polymorphisms.
    Potter JD; Bigler J; Fosdick L; Bostick RM; Kampman E; Chen C; Louis TA; Grambsch P
    Cancer Epidemiol Biomarkers Prev; 1999 Jan; 8(1):69-75. PubMed ID: 9950242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulindac induced regression of colorectal adenomas in familial adenomatous polyposis: evaluation of predictive factors.
    Giardiello FM; Offerhaus JA; Tersmette AC; Hylind LM; Krush AJ; Brensinger JD; Booker SV; Hamilton SR
    Gut; 1996 Apr; 38(4):578-81. PubMed ID: 8707091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic polymorphisms of flavin monooxygenase 3 in sulindac-induced regression of colorectal adenomas in familial adenomatous polyposis.
    Hisamuddin IM; Wehbi MA; Schmotzer B; Easley KA; Hylind LM; Giardiello FM; Yang VW
    Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2366-9. PubMed ID: 16214918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sulindac inhibits beta-catenin expression in normal-appearing colon of hereditary nonpolyposis colorectal cancer and familial adenomatous polyposis patients.
    Koornstra JJ; Rijcken FE; Oldenhuis CN; Zwart N; van der Sluis T; Hollema H; deVries EG; Keller JJ; Offerhaus JA; Giardiello FM; Kleibeuker JH
    Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1608-12. PubMed ID: 16030090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Rectal micropolyps after total colectomy in familial polyposis. Efficacy of sulindac].
    Charneau J; D'Aubigny N; Burtin P; Person B; Boyer J
    Gastroenterol Clin Biol; 1990; 14(2):153-7. PubMed ID: 2158470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenocarcinoma in the rectal segment in familial polyposis coli is not prevented by sulindac therapy.
    Niv Y; Fraser GM
    Gastroenterology; 1994 Sep; 107(3):854-7. PubMed ID: 8076772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of nonsteroidal anti-inflammatory drugs (NSAID) on colorectal polyps in patients with familial adenomatous polyposis: a review of clinical studies].
    Akasu T; Kakizoe T
    Nihon Geka Gakkai Zasshi; 1998 Jun; 99(6):385-90. PubMed ID: 9695077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term treatment with sulindac in familial adenomatous polyposis: is there an actual efficacy in prevention of rectal cancer?
    Tonelli F; Valanzano R; Messerini L; Ficari F
    J Surg Oncol; 2000 May; 74(1):15-20. PubMed ID: 10861602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulindac causes rapid regression of preexisting tumors in Min/+ mice independent of prostaglandin biosynthesis.
    Chiu CH; McEntee MF; Whelan J
    Cancer Res; 1997 Oct; 57(19):4267-73. PubMed ID: 9331087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chemoprevention of familial cancer].
    Ishikawa H
    Gan To Kagaku Ryoho; 1997 Jun; 24(8):951-7. PubMed ID: 9212803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulindac suppression of colorectal polyps in Gardner's syndrome.
    Friend WG
    Am Fam Physician; 1990 Mar; 41(3):891-4. PubMed ID: 2305666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.